Humacyte, Inc. — Investor Relations & Filings
Humacyte, Inc. is a regenerative medicine company that develops and manufactures universally implantable, bioengineered human tissues. The company utilizes a proprietary platform to produce acellular tissues that are designed to be available "off-the-shelf." Upon implantation, these tissues are repopulated by the patient's own cells, remodeling over time to become living tissue. Its first U.S. FDA-approved product, SYMVESS™, is a human acellular vessel (HAV) developed for arterial replacement and repair, particularly in cases of vascular trauma. Humacyte is leveraging its foundational technology to build a pipeline of product candidates for a broad range of diseases, injuries, and chronic conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM S-8 | 2026-05-14 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13D/A - Humacyte, Inc. (0001818382) (Subject) | 2026-03-24 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | |
| 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | |
| Major Shareholding Notification 2026 | 2026-01-09 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46302034 | FORM S-8 | 2026-05-14 | English | ||
| 36127809 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-04-24 | English | ||
| 33023654 | SCHEDULE 13D/A - Humacyte, Inc. (0001818382) (Subject) | 2026-03-24 | English | ||
| 32989361 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | ||
| 32986332 | 8-K - Humacyte, Inc. (0001818382) (Filer) | 2026-03-19 | English | ||
| 13272830 | Major Shareholding Notification 2026 | 2026-01-09 | English | ||
|
2025
9 filings
| |||||
| 13272831 | FORM 8-K | 2025-12-16 | English | ||
| 13272832 | 424B5 | 2025-12-16 | English | ||
| 13272849 | FORM 8-K | 2025-12-15 | English | ||
| 13272848 | FORM 8-K | 2025-12-15 | English | ||
| 13272850 | 424B3 | 2025-12-15 | English | ||
| 13272833 | OWNERSHIP DOCUMENT | 2025-12-08 | English | ||
| 13272837 | FORM 8-K | 2025-11-26 | English | ||
| 13272834 | FORM 4 | 2025-11-17 | English | ||
| 13272835 | FORM 4 | 2025-11-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-onc…
|
ATORX | SE | Manufacturing |
|
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and dispo…
|
002950 | CN | Manufacturing |
|
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cance…
|
ALLO | US | Manufacturing |
|
Almirall S.A.
Global biopharmaceutical company specializing in medical de…
|
ALM | ES | Manufacturing |
|
ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RN…
|
ALNY | US | Manufacturing |
|
Alpa Laboratories Limited
WHO-GMP certified manufacturer of human and veterinary phar…
|
ALPA | IN | Manufacturing |
|
Alpha Cognition Inc.
A biopharmaceutical company developing treatments for neuro…
|
ACOG | CA | Manufacturing |
|
Alphamab Oncology
Innovative biopharma specializing in differentiated anti-tu…
|
9966 | KY | Manufacturing |
|
Alpha Teknova, Inc.
Manufacturer of critical reagents for the life sciences ind…
|
TKNO | US | Manufacturing |
|
ALTERITY THERAPEUTICS LTD
A clinical-stage biotech developing novel treatments for ne…
|
ATHE | US | Manufacturing |
Humacyte, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33410/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33410 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33410 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33410 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33410}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Humacyte, Inc. (id: 33410)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.